Clinically meaningful and statistically significant results from the Phase 3 BREAKWATER trial show objective response rate of 61% with Pfizer…
Read More »Improved
Investing.com — Goldman Sachs CEO, David Solomon, stressed the importance of strengthening bilateral ties between the U.S. and China, the…
Read More »Investing.com — Progyny (NASDAQ:), a company specializing in fertility benefits management, reported a 5.8% increase in its premarket value after…
Read More »It's been almost five months since I decided to stop drinking alcohol, and it has completely changed my social life…
Read More »